Dr. Ilaria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
462 First Avenue
New York, NY 10016- Is this information wrong?
Summary
- Dr. Robert Ilaria is an oncologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Richard L. Roudebush Veterans Affairs Medical Center and NYC Health + Hospitals / Bellevue. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 30 years. He specializes in hematologic oncology and sarcoma and is experienced in multiple myeloma, sarcomas, leukemia, and clinical drug development. He has more than 40 publications and over 500 citings.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1993
- Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990
- University of Texas Southwestern Medical SchoolClass of 1987
Certifications & Licensure
- NJ State Medical License Current
- NY State Medical License 2019 - 2026
- IN State Medical License 2005 - 2021
- TX State Medical License 1999 - 2008
- MA State Medical License 1989 - 2000
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsRandomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer.Oliver W. Hakenberg, Jose Luis Perez-Gracia, Daniel Castellano, Tomasz Demkow, Tarek Ali, Orazio Caffo, Axel Heidenreich, Wolfgang Schultze-Seemann, Brieuc Sautois, Iv...> ;European Journal of Cancer. 2019 Jan 1
- 10 citationsExposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L. Jones, Gary Mo, John R. Baldwin, Patrick Peterson, Robert Ilaria, Ilaria Conti, Damien M. Cronier, William D. Tap> ;Cancer Chemotherapy and Pharmacology. 2019 Jan 1
- 25 citationsRandomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or plati...William P. McGuire, Richard T. Penson, Martin Gore, Antonio Casado Herraez, Patrick Peterson, Ashwin Shahir, Robert Ilaria> ;BMC Cancer. 2018 Dec 27
- Join now to see all
Press Mentions
- Infinity Pharmaceuticals to Be Featured in B. Riley Fireside ChatDecember 13th, 2021
Professional Memberships
- Member
Hospital Affiliations
- Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indiana
- NYC Health + Hospitals / BellevueNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: